Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Account Payables (2016 - 2025)

Jaguar Health (JAGX) has disclosed Change in Account Payables for 11 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 300.88% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.8 million, a 732.89% increase, with the full-year FY2024 number at $328000.0, up 138.36% from a year prior.
  • Change in Account Payables was $1.8 million for Q3 2025 at Jaguar Health, up from -$438000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.9 million in Q2 2022 to a low of -$1.7 million in Q1 2024.
  • A 5-year average of $191052.6 and a median of $259000.0 in 2021 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: crashed 1515.0% in 2021, then soared 643.24% in 2022.
  • Jaguar Health's Change in Account Payables stood at $1.1 million in 2021, then tumbled by 142.74% to -$489000.0 in 2022, then surged by 62.17% to -$185000.0 in 2023, then soared by 505.95% to $751000.0 in 2024, then skyrocketed by 141.28% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Change in Account Payables are $1.8 million (Q3 2025), -$438000.0 (Q2 2025), and $1.7 million (Q1 2025).